Hlavní stranaMezinárodní biotech události13th Conference on ADMET

13th Conference on ADMET

 

Holiday Inn Kensington Forum, London, UK (July, 9 - 10, 2018)

SMi presents the 13th Conference on ADMET

 

Exploring the optimisation of ADMET modelling techniques, preclinical DMPK applications and development of biopharmaceuticals

 

Conference:  Monday 9th – Tuesday 10th July 2018

 

Location: Holiday Inn Kensington Forum, London, UK

Website: https://www.smi-online.co.uk/pharmaceuticals/uk/admet

 

SMi is delighted to announce the 13th annual ADMET conference returning to London on the 9th - 10th July 2018, featuring.

Developments in ADMET and novel technologies determine the properties of a drug candidate in the preclinical stage of drug discovery. Poor ADMET properties are the principal cause for a candidate to fail at any stage of drug development. ADME-Toxicology and Pharmacokinetic studies are the key strategic check-points for pharmaceutical companies to reduce drug discovery cost and minimise production times.

The growing use of ADMET technologies is driving the market growth, which is estimated to reach $14,319.9 Million by 2022, with a CAGR of 10.6% from 2016 to 2022*. The main objective of early prediction of ADME properties of a compound is to increase the success rate of it reaching the development stage.

*Source: http://bit.ly/2hMJcgU

WHO SHOULD ATTEND

 

·         DMPK Professionals

·         Pharmacologists

·         Computational Scientists

·         Medicinal Chemists

·         Statisticians

·         Principle scientist

·         Drug Metabolism Experts

·         ADME Toxicologists

·         Research fellows

·         PK/PD modelling

·         Toxicologist

·         Anatomists

 

Join our expert speaker panels at the ADMET conference to ensure you do not miss out on the latest developments!

Presenting new technologies, specific case studies and PK modelling strategies in the areas of DMPK, PBPK, PKPD, in vitro / ex vivo / in vivo / in silico, biologics, transporters, hazard and safety assessments, ADMET modelling, and many more.

This event is CPD accredited.

 

#SMiADMET

OPPI, MPO, EU
Czech Bio

Doporučujeme

Biosimilars

CEBIO a I. etapa JVTP

  • CEBIO
  • BC AV CR
  • Budvar
  • CAVD
  • CZBA
  • Eco Tend
  • Envisan Gem
  • Gentrend
  • JAIP
  • Jihočeská univerzita
  • Madeta
  • Forestina
  • ALIDEA

Provozovatel

Jihočeská agentura pro podporu inovačního podnikání o.p.s.

Články na přání


[načítám anketu]

LinkedIn